Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsDrreddyslaboratories

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Sell IndusInd Bank; buy Dr Reddy's Labs, Dish TV: Gaurav Bissa

      Gaurav Bissa of LKP Securities is of the view that one can sell IndusInd Bank and buy Dr Reddy's Labs, Dish TV and Engineers India.

    • Prefer Dr Reddy's Labs, buy metals on correction: Gujral

      Ashwani Gujral of ashwanigujral.com prefers Dr Reddy's Laboratories over Tata Power and feels that one can buy metal stocks on correction.

    • Invest in Dr Reddy's Labs; sell Adani Ports, DLF: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can invest in Dr Reddy's Labs and sell Adani Ports, DLF and Indiabulls Real Estate.

    • Buy Dr Reddy's 3050 Put, says VK Sharma

      VK Sharma of HDFC Securities advises buying Dr Reddy's Laboratories 3050 Put.

    • Six stocks that you can bet on June 10

      Jay Thakkar of Sharekhan recommends buying SAIL with a target of Rs 49 and Dhampur Sugar with a target of Rs 108.

    • Buy Biocon, Dr Reddy's Lab: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may buy Biocon on declines.

    • Sell Godrej Consumer Products, CSEC: Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that one can sell Godrej Consumer and CSEC and feels that Eicher Motors may hit Rs 18000.

    • TCS may test Rs 2680, Dr Reddy's Rs 3240, Titan Rs 390: Gaba

      Prakash Gaba of prakashgaba.com is of the view that TCS may test Rs 2680, Dr Reddy's Labs may hit Rs 3240 while Titan Company may head to Rs 390.

    • Super Six: Top chart picks for May 26

      Jay Thakkar of Sharekhan is of the view that one may buy TVS Motor with a target of Rs 313.

    • Infosys, HDFC Bank, Aurobindo are top picks: R Sreesankar

      R Sreesankar, Head Institutional Equities, Prabhudas Lilladher in an interview to CNBC-TV18 shared his rationale for picking Infosys, HDFC Bank, Aurobindo Pharma, Jubilant Life and Glenmark as his top picks.

    • Sell Dish TV, Asian Paints; buy CESC: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can sell Dish TV and Asian Paints and buy CESC.

    • Buy Ajanta Pharma, IndusInd Bank, Arvind: Chandan Taparia

      Chandan Taparia of Anand Rathi Securities recommends buying Ajanta Pharma, IndusInd Bank and Arvind and feels that Dr Reddy‘s Laboratories may hit Rs 380.

    • Buy Bajaj Finance; sell Canara Bank, Rel Infra: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Bajaj Finance and sell Canara Bank and Reliance Infra.

    • Pick Dr Reddy's Lab at lower levels: Deven Choksey

      Deven Choksey of KRChoksey Investment Managers is of the view that one may pick Dr Reddy's Laboratories at lower levels.

    • Sell Tata Motors; avoid Dr Reddy's Labs: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends selling Tata Motors and advises avoiding Dr Reddy's Labs.

    • Here is why SP Tulsian is bullish on Ujjivan Financial

      In an interview with CNBC-TV18, SP Tulsian, sptulsian.com, shares his views on the microfinance space and sugar stocks.

    • Buy Maruti Suzuki on all declines: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Maruti Suzuki on all declines.

    • Buy Dr Reddy's Laboratories at around Rs 2700-2750: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can buy Dr Reddy's Laboratories at around Rs 2700-2750.

    • Buy UPL, GNFC, Dr Reddy's Labs: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying UPL, Gujarat Narmada Valley Fertilizers & Chemicals and Dr Reddy's Labs.

    • Buy Reliance Capital, SRF, Aurobindo Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Reliance Capital, SRF and Aurobindo Pharma.

    • Sell BPCL, Coal India, Dr Reddy's Labs: Rajat Bose

      Rajat Bose of rajatkbose.com recommends selling BPCL, Coal India and Dr Reddy's Labs.

    • 6 stock ideas to liven up your trade

      Sameet Chavan of Angel Broking recommends buying Cairn India with a target of Rs 162 and Vedanta with a target of Rs 116.

    • Buy L&T, Ashok Leyland, Dr Reddy's Lab: Rajat Bose

      Rajat Bose of rajatkbose.com advises buying Ashok Leyland, Dr Reddy's Laboratories and Larsen and Toubro.

    • Buy Dr Reddy's Labs, Hindalco may test Rs 105: Rajat Bose

      Rajat Bose of rajatkbose.com recommends buying Dr Reddy's Laboratories and feels that Hindalco Industries may test Rs 105.

    • Exit Marksans Pharma, says Vijay Chopra

      Vijay Chopra of enochventures.com is of the view that one may exit Marksans Pharma.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347